ArticleEuropean journal of pediatrics2025
Navigating end-of-life decision-making on ECLS discontinuation in children: insights from the international ENSURE survey.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Healthcare professionals face significant challenges when deciding whether to continue or withdraw Extracorporeal Life Support (ECLS) in pediatric patients, which may cause moral distress. The ENd-of-life deciSion-making dURing ECLS (ENSURE) survey investigates the perspectives of European healthcare professionals on ECLS discontinuation in pediatric patients considering the potential impact of cultural, religious, and regional factors. A 23-item mixed-method questionnaire survey was conducted across 21 European countries in different languages, assessing respondent demographics, ethical viewpoints, and institutional practices. The analysis focused on differences in decision-making based on geographic region, profession, and religion. A total of 192 healthcare professionals participated, with 68% from ELSO centers. Most respondents (77%) agreed that ethics consultations would benefit patients and families when ECLS fails to meet treatment goals. Preferences for discontinuing ECLS varied regionally, with practitioners from Northern and Western Europe more likely to favor the discontinuation of ECLS with comfort care (62-68%) compared to those from Southern and Eastern Europe (34-50%). Religious beliefs might influence decisions, with Christian and agnostic/atheist participants more likely to support ECLS discontinuation.
conclusionDecision-making surrounding ECLS discontinuation in pediatric patients is influenced by regional, cultural, and possibly religious factors. There is a need for standardized guidelines and expanded access to ethics consultations to support healthcare professionals and reduce moral distress in these complex cases. Addressing discordance in clinical teams and enhancing palliative care access may improve the decision-making process and patient care outcomes. WHAT IS KNOWN: •Decisions about ECLS withdrawal in pediatric patients are ordinarily made in close consultation with families, who are particularly influenced by emotional factors. •There is a scarcity of literature related to the ethics of ECLS initiation, continuation, and termination in children, providing minimal, specific ethical recommendations. WHAT IS NEW: •The ENSURE study evaluates current viewpoints of ECLS professionals across Europe and investigates influencing respondent or institutional characteristics. •Guidelines for managing ECLS patients considering regional, religious, and cultural factors could reduce variability in treatment and mental distress in decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.